Toxicokinetics Flashcards
1
Q
Absorption Drug Variables (6)
A
- Dose: sheer bulk extends absorption with delayed/wide [peak]
- Formulation
- Water Solubility
- Slowed gut motility
- Increased gut motility
- First pass effect
2
Q
Formulation Effects
A
- Liquids may have enhanced absorption due to volume stimulating gastric emptying
- EC and SR are designed to prolong absorption
- Excipients form concretions (phenytoin)
3
Q
Water Solubility
A
- Poor water solubility has prolonged absorption
- Phenytoin Cmax increases significantly with dose increases
- Carbamazepine has a wider plateau
- Aspirin solubility increases in alkaline medium due to ionized form, net result is increased absorption
4
Q
Gut Motility
A
- TCA, phenothiazines, antihistamines**, anticholinergics, CCB, opioids
- Total drug absorbed increases due to prolonged contact
- Increased gut motility: salicylates, theophylline
- Emesis decreased total amount absorbed
5
Q
First Pass Effect
A
- Saturable in overdose, resulting in less presystemic clearance and higher blood levels
- Drugs: opioids, verapamil, lidocaine, propranolol, TCA
- Removal of drug after ingestion: gut enzymes, liver uptake, vomiting, AC, WBI, etc.
6
Q
Absorption Pathophysiology Effects
A
- Hypothermia or hypotension decreases mesenteric perfusion and decreases/delays absorption
- CCB, B-blockers, procainamide
7
Q
High First Pass Effect Drugs
A
- Propranolol
- Cyclosporine
- Morphine
- Desipramine and other TCAs
- Implications: first pass effect can saturate in overdose, greater proportion of drug will reach systemic circulation
8
Q
Large Vd Drugs
A
- Camphor
- Antidepressants
- Digoxin
- Opioids
- Phenothiazines
9
Q
Small Vd Drugs
A
- Alcohol
- Lithium
- Phenobarbital
- Phenytoin
- Salicylate
- Valproic Acid
10
Q
Vd + [Peak]
A
- Vd can use to predict max [peak] or body burden in overdose
- Cp = Dose/Vd
11
Q
Compartments
A
- Part of distribution
- Shallow peripheral: highly perfused organs, brain, liver, kidneys
- When rapidly equilibrated, one compartment model is evident
- Deep peripheral: slow distribution to muscle, adipose tissue, bone
12
Q
Protein Binding
A
- Part of distribution
- Poly-drug overdose: competes for binding sites
- High dose: can saturate protein binding resulting in higher free levels
- Drugs not normally considered dialyzable may be so in overdose (valproic acid, salicylates)
13
Q
Increased Vd
A
- Increased Vd in chronic vs acute overdose produce toxicity at levels considered mildly toxic or therapeutic in acute overdose
- Ex: theophylline, salicylate, lithium
- Cause a [gradient] created by chronically elevated serum levels, leading to increased tissue compartment stores
14
Q
Drug Metabolism + Overdose
A
- Altered rate of biotransformation
- Prominence of enterohepatic recirculation
- Relative utilization of elimination routes
- Relative utilization of elimination routes
- Impact of toxic or active metabolites
15
Q
Phase I Metabolism
A
- CYP P450s, hydroxylation, demethylation, epoxidation
- Metabolites excreted into bile, transported from central compartment for renal elimination, or further metabolized
- Drugs w/ active metabolites: TCA, diazepam, meperidine